Full Text Journal Articles by
Author Alberico L Catapano

Advertisement

Find full text journal articles






Insights from ORION studies: focus on inclisiran safety.

Alberico L Catapano, Angela Pirillo, Giuseppe D Norata,

Cardiovasc. Res. (Cardiovascular research)
[2020, :]

Cited: 0 times

View full text PDF listing >>



Balancing cardiovascular benefit and diabetogenic harm of therapy with statins: Real-world evidence from Italy.

Giovanni Corrao, Matteo Monzio Compagnoni, Anna Cantarutti, Federico Rea, Luca Merlino, Alberico L Catapano, Giuseppe Mancia,

AIM:To provide information on the balance between the cardiovascular (CV) benefit and the diabetogenic harm of statin therapy in the current clinical practice. METHODS:All the 115,939 residents (older than 50 years) in the Italian Lombardy Region newly treated with statins between 2003 and 2005, were followed from the first statin prescription ... Read more >>

Diabetes Res. Clin. Pract. (Diabetes research and clinical practice)
[2020, 164:108197]

Cited: 0 times

View full text PDF listing >>



Advertisement

LDL-Cholesterol-Lowering Therapy.

Angela Pirillo, Giuseppe D Norata, Alberico L Catapano,

The causal relation between elevated levels of LDL-C and cardiovascular disease has been largely established by experimental and clinical studies. Thus, the reduction of LDL-C levels is a major target for the prevention of cardiovascular disease. In the last decades, statins have been used as the main therapeutic approach to ... Read more >>

Handb Exp Pharmacol (Handbook of experimental pharmacology)
[2020, :]

Cited: 0 times

View full text PDF listing >>



The year 2019 in Atherosclerosis.

Christoph J Binder, Jan Borén, Alberico L Catapano, Geesje Dallinga-Thie, Florian Kronenberg, Ziad Mallat, Simona Negrini, Paolo Raggi, Arnold von Eckardstein,

Atherosclerosis (Atherosclerosis)
[2020, 299:67-75]

Cited: 0 times

View full text PDF listing >>



Association between the cumulative exposure to bisphosphonates and hospitalization for atherosclerotic cardiovascular events: A population-based study.

Manuela Casula, Elena Olmastroni, Federica Galimberti, Elena Tragni, Giovanni Corrao, Lorenza Scotti, Alberico L Catapano,

BACKGROUND AND AIMS:Although bisphosphonates have been suggested to protect against atherosclerotic cardiovascular (CV) events, evidence is still conflicting. We aimed at investigating the effect of bisphosphonates on hospitalizations for atherosclerotic CV events. METHODS:We carried out a retrospective cohort study selecting subjects aged>40 years, incident users of bisphosphonates. Exposure to bisphosphonates ... Read more >>

Atherosclerosis (Atherosclerosis)
[2020, 301:1-7]

Cited: 0 times

View full text PDF listing >>



Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel.

Jan Borén, M John Chapman, Ronald M Krauss, Chris J Packard, Jacob F Bentzon, Christoph J Binder, Mat J Daemen, Linda L Demer, Robert A Hegele, Stephen J Nicholls, Børge G Nordestgaard, Gerald F Watts, Eric Bruckert, Sergio Fazio, Brian A Ference, Ian Graham, Jay D Horton, Ulf Landmesser, Ulrich Laufs, Luis Masana, Gerard Pasterkamp, Frederick J Raal, Kausik K Ray, Heribert Schunkert, Marja-Riitta Taskinen, Bart van de Sluis, Olov Wiklund, Lale Tokgozoglu, Alberico L Catapano, Henry N Ginsberg,

Eur. Heart J. (European heart journal)
[2020, :]

Cited: 0 times

View full text PDF listing >>



LIPA gene mutations affect the composition of lipoproteins: Enrichment in ACAT-derived cholesteryl esters.

Lorenzo Arnaboldi, Alice Ossoli, Eleonora Giorgio, Livia Pisciotta, Tiziano Lucchi, Liliana Grigore, Chiara Pavanello, Agnese Granata, Andrea Pasta, Beatrice Arosio, Domenico Azzolino, Andrea Baragetti, Samuela Castelnuovo, Alberto Corsini, Alberico L Catapano, Laura Calabresi, Monica Gomaraschi,

BACKGROUND AND AIMS:Cholesteryl ester storage disease (CESD) due to LIPA gene mutations is characterized by hepatic steatosis, hypercholesterolemia and hypoalphalipoproteinemia, exposing affected patients to an increased cardiovascular risk. Further insights into the impact of LIPA gene mutations on lipid/lipoprotein metabolism are limited. Aim of the study was to investigate the ... Read more >>

Atherosclerosis (Atherosclerosis)
[2020, 297:8-15]

Cited: 0 times

View full text PDF listing >>



Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action.

, Katherine A Wilemon, Jasmine Patel, Carlos Aguilar-Salinas, Catherine D Ahmed, Mutaz Alkhnifsawi, Wael Almahmeed, Rodrigo Alonso, Khalid Al-Rasadi, Lina Badimon, Luz M Bernal, Martin P Bogsrud, Lynne T Braun, Liam Brunham, Alberico L Catapano, Kristyna Cillíková, Pablo Corral, Regina Cuevas, Joep C Defesche, Olivier S Descamps, Sarah de Ferranti, Jean-Luc Eiselé, Gerardo Elikir, Emanuela Folco, Tomas Freiberger, Francesco Fuggetta, Isabel M Gaspar, Ákos G Gesztes, Urh Grošelj, Ian Hamilton-Craig, Gabriele Hanauer-Mader, Mariko Harada-Shiba, Gloria Hastings, G Kees Hovingh, Maria C Izar, Allison Jamison, Gunnar N Karlsson, Meral Kayikçioglu, Sue Koob, Masahiro Koseki, Stacey Lane, Marcos M Lima-Martinez, Greizy López, Tania L Martinez, David Marais, Letrillart Marion, Pedro Mata, Inese Maurina, Diana Maxwell, Roopa Mehta, George A Mensah, André R Miserez, Dermot Neely, Stephen J Nicholls, Atsushi Nohara, Børge G Nordestgaard, Leiv Ose, Athanasios Pallidis, Jing Pang, Jules Payne, Amy L Peterson, Monica P Popescu, Raman Puri, Kausik K Ray, Ashraf Reda, Tiziana Sampietro, Raul D Santos, Inge Schalkers, Laura Schreier, Michael D Shapiro, Eric Sijbrands, Daniel Soffer, Claudia Stefanutti, Mario Stoll, Rody G Sy, Martha L Tamayo, Myra K Tilney, Lale Tokgözoglu, Brian Tomlinson, Antonio J Vallejo-Vaz, Alejandra Vazquez-Cárdenas, Patrícia Vieira de Luca, David S Wald, Gerald F Watts, Nanette K Wenger, Michaela Wolf, David Wood, Aram Zegerius, Thomas A Gaziano, Samuel S Gidding,

Importance:Familial hypercholesterolemia (FH) is an underdiagnosed and undertreated genetic disorder that leads to premature morbidity and mortality due to atherosclerotic cardiovascular disease. Familial hypercholesterolemia affects 1 in 200 to 250 people around the world of every race and ethnicity. The lack of general awareness of FH among the public and ... Read more >>

JAMA Cardiol (JAMA cardiology)
[2020, :]

Cited: 0 times

View full text PDF listing >>



Beyond LDL-C levels, does remnant cholesterol estimation matter?

Angela Pirillo, Giuseppe D Norata, Alberico L Catapano,

Eur J Prev Cardiol (European journal of preventive cardiology)
[2020, :2047487319899622]

Cited: 0 times

View full text PDF listing >>



2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.

François Mach, Colin Baigent, Alberico L Catapano, Konstantinos C Koskinas, Manuela Casula, Lina Badimon, M John Chapman, Guy G De Backer, Victoria Delgado, Brian A Ference, Ian M Graham, Alison Halliday, Ulf Landmesser, Borislava Mihaylova, Terje R Pedersen, Gabriele Riccardi, Dimitrios J Richter, Marc S Sabatine, Marja-Riitta Taskinen, Lale Tokgozoglu, Olov Wiklund, ,

Eur. Heart J. (European heart journal)
[2020, 41(1):111-188]

Cited: 13 times

View full text PDF listing >>



Update on cardiovascular prevention in clinical practice: A position paper of the European Association of Preventive Cardiology of the European Society of Cardiology.

Massimo F Piepoli, Ana Abreu, Christian Albus, Marco Ambrosetti, Carlos Brotons, Alberico L Catapano, Ugo Corra, Bernard Cosyns, Christi Deaton, Ian Graham, Arno Hoes, Maja-Lisa Lochen, Benedetta Matrone, Josep Redon, Naveed Sattar, Yvo Smulders, Monica Tiberi,

European guidelines on cardiovascular prevention in clinical practice were first published in 1994 and have been regularly updated, most recently in 2016, by the Sixth European Joint Task Force. Given the amount of new information that has become available since then, components from the task force and experts from the ... Read more >>

Eur J Prev Cardiol (European journal of preventive cardiology)
[2020, 27(2):181-205]

Cited: 0 times

View full text PDF listing >>



Corrigendum to "2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140-205].

, , ,

Atherosclerosis (Atherosclerosis)
[2020, 294:80-82]

Cited: 0 times

View full text PDF listing >>



Erratum to "2019 ESC/EAS guidelines for the management of dyslipidemias: Lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140-205].

, , ,

Atherosclerosis (Atherosclerosis)
[2020, 292:160-162]

Cited: 0 times

View full text PDF listing >>



Sex-differences in factors and outcomes associated with adherence to statin therapy in primary care: Need for customisation strategies.

Elena Olmastroni, Mezio T Boccalari, Elena Tragni, Federico Rea, Luca Merlino, Giovanni Corrao, Alberico L Catapano, Manuela Casula,

Despite the invaluable efficacy of statins, adherence to therapy is extremely poor in clinical practice. Improvement interventions should be as personalized as possible, but it is necessary to know factors that most influence adherence, and sex seems to be a key determinant. Thus, we aimed at exploring potential areas of ... Read more >>

Pharmacol. Res. (Pharmacological research)
[2020, 155:104514]

Cited: 0 times

View full text PDF listing >>



Cholesterol membrane content has a ubiquitous evolutionary function in immune cell activation: the role of HDL.

Fabrizia Bonacina, Angela Pirillo, Alberico L Catapano, Giuseppe D Norata,

PURPOSE OF REVIEW:Cellular cholesterol content influences the structure and function of lipid rafts, plasma membrane microdomains essential for cell signaling and activation. HDL modulate cellular cholesterol efflux, thus limiting cholesterol accumulation and controlling immune cell activation. Aim of this review is to discuss the link between HDL and cellular cholesterol ... Read more >>

Curr. Opin. Lipidol. (Current opinion in lipidology)
[2019, 30(6):462-469]

Cited: 0 times

View full text PDF listing >>



Progression of conventional cardiovascular risk factors and vascular disease risk in individuals: insights from the PROG-IMT consortium.

Martin Bahls, Matthias W Lorenz, Marcus Dörr, Lu Gao, Kazuo Kitagawa, Tomi-Pekka Tuomainen, Stefan Agewall, Gerald Berenson, Alberico L Catapano, Giuseppe D Norata, Michiel L Bots, Wiek van Gilst, Folkert W Asselbergs, Frank P Brouwers, Heiko Uthoff, Dirk Sander, Holger Poppert, Michael Hecht Olsen, Jean Philippe Empana, Ulf Schminke, Damiano Baldassarre, Fabrizio Veglia, Oscar H Franco, Maryam Kavousi, Eric de Groot, Ellisiv B Mathiesen, Liliana Grigore, Joseph F Polak, Tatjana Rundek, Coen DA Stehouwer, Michael R Skilton, Apostolos I Hatzitolios, Christos Savopoulos, George Ntaios, Matthieu Plichart, Stela McLachlan, Lars Lind, Peter Willeit, Helmuth Steinmetz, Moise Desvarieux, M Arfan Ikram, Stein Harald Johnsen, Caroline Schmidt, Johann Willeit, Pierre Ducimetiere, Jackie F Price, Göran Bergström, Jussi Kauhanen, Stefan Kiechl, Matthias Sitzer, Horst Bickel, Ralph L Sacco, Albert Hofman, Henry Völzke, Simon G Thompson, ,

AIMS:Averaged measurements, but not the progression based on multiple assessments of carotid intima-media thickness, (cIMT) are predictive of cardiovascular disease (CVD) events in individuals. Whether this is true for conventional risk factors is unclear. METHODS AND RESULTS:An individual participant meta-analysis was used to associate the annualised progression of systolic blood ... Read more >>

Eur J Prev Cardiol (European journal of preventive cardiology)
[2020, 27(3):234-243]

Cited: 0 times

View full text PDF listing >>



Dietary linoleic acid and human health: Focus on cardiovascular and cardiometabolic effects.

Franca Marangoni, Carlo Agostoni, Claudio Borghi, Alberico L Catapano, Hellas Cena, Andrea Ghiselli, Carlo La Vecchia, Giovanni Lercker, Enzo Manzato, Angela Pirillo, Gabriele Riccardi, Patrizia Risé, Francesco Visioli, Andrea Poli,

This narrative review aims to discuss the more relevant evidence on the role of linoleic acid (LA), a n-6 essential fatty acid that constitutes the predominant proportion of dietary polyunsaturated fatty acids (PUFA), in cardiovascular health. Although LA can be metabolized into Arachidonic Acid (AA), a 20 carbon PUFA which ... Read more >>

Atherosclerosis (Atherosclerosis)
[2020, 292:90-98]

Cited: 0 times

View full text PDF listing >>



Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement.

Robert A Hegele, Jan Borén, Henry N Ginsberg, Marcello Arca, Maurizio Averna, Christoph J Binder, Laura Calabresi, M John Chapman, Marina Cuchel, Arnold von Eckardstein, Ruth Frikke-Schmidt, Daniel Gaudet, G Kees Hovingh, Florian Kronenberg, Dieter Lütjohann, Klaus G Parhofer, Frederick J Raal, Kausik K Ray, Alan T Remaley, Jane K Stock, Erik S Stroes, Lale Tokgözoğlu, Alberico L Catapano,

Genome sequencing and gene-based therapies appear poised to advance the management of rare lipoprotein disorders and associated dyslipidaemias. However, in practice, underdiagnosis and undertreatment of these disorders are common, in large part due to interindividual variability in the genetic causes and phenotypic presentation of these conditions. To address these challenges, ... Read more >>

Lancet Diabetes Endocrinol (The lancet. Diabetes & endocrinology)
[2019, :]

Cited: 1 time

View full text PDF listing >>



Understanding the Patient Perception of Statin Experience: A Qualitative Study.

Michal Vrablik, Alberico L Catapano, Olov Wiklund, Yi Qian, Pratik Rane, Alyson Grove, Mona L Martin,

INTRODUCTION:Statin intolerance (SI) occurs in patients with dyslipidemia treated with statins. Statin-associated symptoms have been reported, but the overall patient experience is poorly understood. No instruments are available to collect this patient experience. Our aim is to develop a patient survey to define SI from the patient's perspective, inform clinical ... Read more >>

Adv Ther (Advances in therapy)
[2019, 36(10):2723-2743]

Cited: 0 times

View full text PDF listing >>



2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk.

, , ,

Atherosclerosis (Atherosclerosis)
[2019, 290:140-205]

Cited: 0 times

View full text PDF listing >>



Comparing remnant lipoprotein cholesterol measurement methods to evaluate efficacy of ezetimibe/statin vs statin therapy.

Peter P Toth, Harold E Bays, W Virgil Brown, Alberico L Catapano, Michael H Davidson, Michel Farnier, Joanne E Tomassini, Erin Jensen, Adam B Polis, Andrew M Tershakovec,

BACKGROUND:Elevated remnant lipoprotein cholesterol (RLP-C) levels increase cardiovascular disease risk. However, RLP-C measurement methods are not standardized, leading to variations across studies. OBJECTIVE:To evaluate the effect of ezetimibe (Eze) + statins vs statin monotherapy on RLP-C using immunoseparation (IM), vertical auto profile (VAP) ultracentrifugation, and calculated RLP-C measurement methods. METHODS:This post ... Read more >>

J Clin Lipidol (Journal of clinical lipidology)
[2019, 13(6):997-1007.e8]

Cited: 0 times

View full text PDF listing >>



The role of red yeast rice (RYR) supplementation in plasma cholesterol control: A review and expert opinion.

Maciej Banach, Eric Bruckert, Olivier S Descamps, Lars Ellegård, Marat Ezhov, Bernhard Föger, Zlatko Fras, Petri T Kovanen, Gustavs Latkovskis, Winfried März, Demosthenes B Panagiotakos, György Paragh, Daniel Pella, Angela Pirillo, Andrea Poli, Željko Reiner, Günter Silbernagel, Margus Viigimaa, Michal Vrablík, Alberico L Catapano,

Atheroscler Suppl (Atherosclerosis. Supplements)
[2019, 39:e1-e8]

Cited: 0 times

View full text PDF listing >>



Treatment with fibrates is associated with higher LAL activity in dyslipidemic patients.

Chiara Pavanello, Andrea Baragetti, Adriana Branchi, Liliana Grigore, Samuela Castelnuovo, Eleonora Giorgio, Alberico L Catapano, Laura Calabresi, Monica Gomaraschi,

Lysosomal acid lipase (LAL) is responsible for the hydrolysis of cholesteryl esters (CE) and triglycerides (TG) within the lysosomes; generated cholesterol and free fatty acids (FFA) are released in the cytosol where they can regulate their own synthesis and metabolism. When LAL is not active, as in case of genetic ... Read more >>

Pharmacol. Res. (Pharmacological research)
[2019, 147:104362]

Cited: 0 times

View full text PDF listing >>



Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia.

Leopoldo Pérez de Isla, Kausik K Ray, Gerald F Watts, Raul D Santos, Rodrigo Alonso, Ovidio Muñiz-Grijalvo, Jose Luis Diaz-Diaz, Lina Badimon, Alberico L Catapano, Pedro Mata,

BACKGROUND AND AIMS:Patients with familial hypercholesterolaemia (FH) may require proprotein convertase subtilisin/kexin-type 9 (PCSK9) mAb as add-on therapy to achieve LDL-cholesterol (LDL-C) goals. However, the current cost of these therapies means that choosing suitable patients is based on consensus or clinical judgement rather than a quantitative risk assessment. We used ... Read more >>

Atherosclerosis (Atherosclerosis)
[2019, 286:40-45]

Cited: 0 times

View full text PDF listing >>



Cholesterol metabolism, pancreatic β-cell function and diabetes.

Carla Perego, Lorenzo Da Dalt, Angela Pirillo, Alessandra Galli, Alberico L Catapano, Giuseppe D Norata,

Cholesterol plays an essential role in determining cell membrane physico-chemical characteristics and functions. A proper membrane structure is critical in pancreatic β-cells for glucose-mediated insulin secretion, and alterations in cellular cholesterol content may negatively affect this process, leading to β-cell dysfunction. The low density lipoprotein receptor (LDL-R) appears to play ... Read more >>

Biochim Biophys Acta Mol Basis Dis (Biochimica et biophysica acta. Molecular basis of disease)
[2019, 1865(9):2149-2156]

Cited: 0 times

View full text PDF listing >>



Advertisement

Disclaimer
1.1596 s